Literature DB >> 34226614

Klotho KL-VS haplotype does not improve cognition in a population-based sample of adults age 55-87 years.

Bernhard W Müller1,2, Anke Hinney3, Norbert Scherbaum4,5, Christian Weimar6,7, Christoph Kleinschnitz8, Triinu Peters3, Lara Hochfeld9, Sonali Pechlivanis7,10, Andreas Stang7, Martha Jokisch8, Bernd Kowall7.   

Abstract

The heterozygous human Klotho KL-VS haplotype has been associated with improved cognitive performance but results are inconsistent. Here we assessed Klotho KL-VS haplotype and cognition using data from the third examination of the population-based Heinz Nixdorf Recall Study. We analyzed cognition tests (immediate and delayed word list, Trail-Making Test [TMT] part A and B, Maze test, interference condition of the Stroop color-word test, verbal fluency) and their associations with Klotho KL-VS haplotype. The Klotho KL-VS haplotype is classified by the V-allele at SNP rs9536314 (F352V) and the S-allele at SNP rs9527025 (C370S). Heterozygotes for the KL-VS haplotype were compared with non-carriers. Analyses were performed in 1812 subjects (55-87 years). We found consistent but only slightly lower performance in heterozygous carriers of the KL-VS haplotype in all tasks with Z-scores ranging between Z = - 0.042 (verbal fluency) and - 0.17 (TMT part A). Differences between carriers and non-carriers were similar for men and women for all tests but TMT part B (interaction contrast = 8.4 s (95% CI - 2.3; 19.1)). While cognition declined with age, we found an effect modification by age (55-65 years, 66-75 years, > 75 years). In the 66-75 years KL-VS heterozygous age group, lower performance was seen in memory, visual attention and motor speed. Contrary to our hypothesis, heterozygous carriers of the KL-VS haplotype did not show enhanced performance in cognitive tests in our study.

Entities:  

Year:  2021        PMID: 34226614     DOI: 10.1038/s41598-021-93211-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  17 in total

1.  Population-based distribution and psychometric properties of a short cognitive performance measure in the population-based Heinz Nixdorf Recall Study.

Authors:  Natalia Wege; Martha Dlugaj; Johannes Siegrist; Nico Dragano; Raimund Erbel; Karl-Heinz Jöckel; Susanne Moebus; Christian Weimar
Journal:  Neuroepidemiology       Date:  2011-07-13       Impact factor: 3.282

2.  Relationship of low plasma klotho with poor grip strength in older community-dwelling adults: the InCHIANTI study.

Authors:  Richard D Semba; Anne R Cappola; Kai Sun; Stefania Bandinelli; Mansi Dalal; Candace Crasto; Jack M Guralnik; Luigi Ferrucci
Journal:  Eur J Appl Physiol       Date:  2011-07-17       Impact factor: 3.078

3.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

4.  Association of human aging with a functional variant of klotho.

Authors:  Dan E Arking; Alice Krebsova; Milan Macek; Milan Macek; Albert Arking; I Saira Mian; Linda Fried; Ada Hamosh; Srabani Dey; Iain McIntosh; Harry C Dietz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 5.  The relevance of α-KLOTHO to the central nervous system: Some key questions.

Authors:  Marina Minto Cararo-Lopes; Caio Henrique Yokoyama Mazucanti; Cristoforo Scavone; Elisa Mitiko Kawamoto; Daniel Charles Berwick
Journal:  Ageing Res Rev       Date:  2017-03-18       Impact factor: 10.895

Review 6.  Molecular basis of Klotho: from gene to function in aging.

Authors:  Yuechi Xu; Zhongjie Sun
Journal:  Endocr Rev       Date:  2015-02-19       Impact factor: 19.871

7.  Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity.

Authors:  Dan E Arking; Gil Atzmon; Albert Arking; Nir Barzilai; Harry C Dietz
Journal:  Circ Res       Date:  2005-01-27       Impact factor: 17.367

8.  Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice.

Authors:  Dena B Dubal; Lei Zhu; Pascal E Sanchez; Kurtresha Worden; Lauren Broestl; Erik Johnson; Kaitlyn Ho; Gui-Qiu Yu; Daniel Kim; Alexander Betourne; Makoto Kuro-O; Eliezer Masliah; Carmela R Abraham; Lennart Mucke
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

9.  Life extension factor klotho enhances cognition.

Authors:  Dena B Dubal; Jennifer S Yokoyama; Lei Zhu; Lauren Broestl; Kurtresha Worden; Dan Wang; Virginia E Sturm; Daniel Kim; Eric Klein; Gui-Qiu Yu; Kaitlyn Ho; Kirsten E Eilertson; Lei Yu; Makoto Kuro-o; Philip L De Jager; Giovanni Coppola; Gary W Small; David A Bennett; Joel H Kramer; Carmela R Abraham; Bruce L Miller; Lennart Mucke
Journal:  Cell Rep       Date:  2014-05-10       Impact factor: 9.423

10.  The longevity gene Klotho is differentially associated with cognition in subtypes of schizophrenia.

Authors:  Bharti Morar; Johanna C Badcock; Michael Phillips; Osvaldo P Almeida; Assen Jablensky
Journal:  Schizophr Res       Date:  2017-07-01       Impact factor: 4.939

View more
  2 in total

1.  Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.

Authors:  Muhammad Ali; Yun Ju Sung; Fengxian Wang; Maria V Fernández; John C Morris; Anne M Fagan; Kaj Blennow; Henrik Zetterberg; Amanda Heslegrave; Per M Johansson; Johan Svensson; Bengt Nellgård; Alberto Lleó; Daniel Alcolea; Jordi Clarimon; Lorena Rami; José Luis Molinuevo; Marc Suárez-Calvet; Estrella Morenas-Rodríguez; Gernot Kleinberger; Christian Haass; Michael Ewers; Johannes Levin; Martin R Farlow; Richard J Perrin; Carlos Cruchaga
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

2.  Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.

Authors:  Payel Kundu; Benjamin Zimmerman; Joseph F Quinn; Jeffrey Kaye; Nora Mattek; Shawn K Westaway; Jacob Raber
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.